The global cancer biomarker testing market was valued at US$ 29.83 Billion in 2023. The market size reached US$ 33.37 Billion in 2024 and is expected to reach US$ 96.53 Billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. https://www.datamintelligence.com/research-report/cancer-biomarker-testing-market